当前位置：
X-MOL 学术
›
Nat. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Nature Immunology ( IF 27.7 ) Pub Date : 2020-03-02 , DOI: 10.1038/s41590-020-0640-6 Michael D Crowther 1 , Garry Dolton 1 , Mateusz Legut 1 , Marine E Caillaud 1 , Angharad Lloyd 1 , Meriem Attaf 1 , Sarah A E Galloway 1 , Cristina Rius 1 , Colin P Farrell 2 , Barbara Szomolay 1, 3 , Ann Ager 1, 3 , Alan L Parker 4 , Anna Fuller 1 , Marco Donia 5 , James McCluskey 6 , Jamie Rossjohn 1, 3, 7, 8 , Inge Marie Svane 5 , John D Phillips 2 , Andrew K Sewell 1, 3
Nature Immunology ( IF 27.7 ) Pub Date : 2020-03-02 , DOI: 10.1038/s41590-020-0640-6 Michael D Crowther 1 , Garry Dolton 1 , Mateusz Legut 1 , Marine E Caillaud 1 , Angharad Lloyd 1 , Meriem Attaf 1 , Sarah A E Galloway 1 , Cristina Rius 1 , Colin P Farrell 2 , Barbara Szomolay 1, 3 , Ann Ager 1, 3 , Alan L Parker 4 , Anna Fuller 1 , Marco Donia 5 , James McCluskey 6 , Jamie Rossjohn 1, 3, 7, 8 , Inge Marie Svane 5 , John D Phillips 2 , Andrew K Sewell 1, 3
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译：
作者更正：全基因组 CRISPR-Cas9 筛选揭示了通过单态 MHC I 类相关蛋白 MR1 普遍存在的 T 细胞癌症靶向。
本文的修订版已发布，可以通过本文顶部的链接访问。
更新日期：2020-04-24
中文翻译：
作者更正：全基因组 CRISPR-Cas9 筛选揭示了通过单态 MHC I 类相关蛋白 MR1 普遍存在的 T 细胞癌症靶向。
本文的修订版已发布，可以通过本文顶部的链接访问。
京公网安备 11010802027423号